The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Biopharma developers face many challenges that span beyond the typical resource and expertise constraints, to also encompass complex scientific challenges such as formulation, solubility, and bioavailability. Every challenge encountered can add risk to your timeline and product quality.
Quick to Clinic™ Small Molecule OSD provides a solution to your scientific, resource, and supply chain challenges so you can make smarter decisions that minimize experimental effort and reduce risk. Our range of integrated CDMO solutions help you address your small molecule’s unique needs and are backed by a global network and industry experts.
Download this fact sheet to learn how the Quick to Clinic solution provides:
- API characterization and solid-state chemistry
- Digital predictive in-silico modeling and analytics solutions
- Formulation development technologies
- Expertise and experience